Loading stock data…
DMAA
$10.57+0.04 (+0.38%)
Market ClosedLast close May 1
Drugs Made In America Acquisition Corp.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Drugs Made In America Acquisition Corp. in the Financial Services sector is trading at $10.57. The stock is currently near its 52-week high of $10.57, remaining 1.9% above its 200-day moving average. Technical signals show neutral RSI of 69 and bullish MACD crossover, explaining why DMAA maintains its current momentum and trend strength. The Whystock Score of 60/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Overbought levels (RSI 69) — risk of consolidation or pullback
Long-term trend bullish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JPMBACGS
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$10.57
Potential Downside
66.7%
Whystock Fair Value$3.52
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
Drugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more b...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$356.22M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
55.61
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
2.55%
Volume
Today's trading volume
406
